20 Hrs
Source:
Financial Times
AstraZeneca and Bristol Myers Deal Falls Apart
A potential merger between major pharmaceutical companies would have signaled a return to large-scale industry consolidations.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)